The MHRA’s Patient Involvement Strategy 2021-25

The MHRA’s Patient Involvement Strategy 2021-25

By Hannah Kerfoot Following the Cumberlege review, published in 2020, the MHRA launched their Patient Involvement Strategy 2021-25. Now, in its final year, Pharmora is taking a look at what has been accomplished and what is still to come.   What is the Patient...
Recent trends in the pharmaceutical industry: Patient-focus

Recent trends in the pharmaceutical industry: Patient-focus

By: Hannah Kerfoot  When attending conferences and conventions in the pharmaceutical industry in the past few years, you might have noticed, as we at Pharmora have, a shift in priorities. Patient-focus has been at the forefront in many industry discussions, and...
Landscape of Sarcoma Treatments Development

Landscape of Sarcoma Treatments Development

By Swetha Babu   Raising awareness about sarcoma is crucial due to its rarity and the challenges associated with its diagnosis and treatment, so we at Pharmora have decided to put together a blog detailing what Sarcoma is, and what the landscape of treatment looks...
Gastric and Oesophageal cancer: Causes and Treatment

Gastric and Oesophageal cancer: Causes and Treatment

By Hannah Kerfoot     Gastric (stomach) cancer and oesophageal cancers are not the most common cancers (accounting for only 2% each of all new cancer cases in the UK), however these cancers are classed as being less survivable. Patients with oesophageal...
Liver cancer: what do you need to know?

Liver cancer: what do you need to know?

By Hannah Kerfoot and Pasha Yuen       Celebrating the awareness week for Less Survivable Cancers, Pharmora would like to contribute to this campaign through a series of blogs. Liver cancer is classed as one of the least survivable cancers, with a survival...